selected publications
- Precision medicine results from equitable representation. Bone marrow transplantation. 2024 Academic Article GET IT
- Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and cellular therapy. 2024 Academic Article GET IT
- Transplant Outcomes in Myelofibrosis: Impact of Donor Type [Cord Blood Grafts Supported by CD34+ selected Cells (Haplo-Cord) vs Matched Donors]. Transplantation and cellular therapy. 2024 Academic Article GET IT
- Haplo-cord transplant. Realizing the potential of umbilical cord blood grafts. - A review of techniques and analysis of outcomes. Leukemia & lymphoma. 2024 Review GET IT
- A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nature communications. 2024 Academic Article GET IT
- Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation. Bone marrow transplantation. 2023 Letter GET IT
-
Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD).
Bone marrow transplantation.
2023
Letter
GET IT
Times cited: 14 - Measurable residual disease after CAR T-cell therapy. Seminars in hematology. 2023 Review GET IT
- Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
- Pre-hematopoietic stem cell transplant rituximab for Epstein-Barr Virus and post-transplant lymphoproliferative disorder prophylaxis in alemtuzumab recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
-
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.
Transplantation and cellular therapy.
2022
Academic Article
GET IT
Times cited: 11 -
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Blood advances.
2022
Academic Article
GET IT
Times cited: 9 - Methods to monitor in vivo expansion and efficacy of CAR-T cells in preclinical models. 2021 GET IT
- Allogeneic transplant graft source - conditioning - GVHD prophylaxis: don't mix and match!. Leukemia & lymphoma. 2021 Comment GET IT
-
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes.
Leukemia & lymphoma.
2021
Academic Article
GET IT
Times cited: 1 -
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2021
Academic Article
GET IT
Times cited: 32 - Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML. Frontiers in oncology. 2021 Academic Article GET IT
- Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
-
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
Bone marrow transplantation.
2020
Academic Article
GET IT
Times cited: 3 - Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series. Bone marrow transplantation. 2020 Article GET IT
-
Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia.
Current opinion in hematology.
2020
Information Resource
GET IT
Times cited: 2 -
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma.
Bone marrow transplantation.
2019
Academic Article
GET IT
Times cited: 12 -
Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution Experience.
Clinical lymphoma, myeloma & leukemia.
2018
Academic Article
GET IT
Times cited: 1 -
Minimal Residual Disease in Acute Myeloid Leukemia.
Advances in experimental medicine and biology.
2018
Article
GET IT
Times cited: 5 -
Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?.
American journal of hematology.
2016
Academic Article
GET IT
Times cited: 6 -
Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma.
American journal of hematology.
2015
Academic Article
GET IT
Times cited: 7 -
Clinical outcomes in breast cancer patients with HIV/AIDS: a retrospective study.
Breast cancer research and treatment.
2015
Academic Article
GET IT
Times cited: 14 -
Distribution and trends of hematology and oncology research in Latin America: A decade of uncertainty.
Cancer.
2013
Academic Article
GET IT
Times cited: 14